Corbevax, Vaccine

The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions, official sources said.The country's central drug authority is expected to give final approval to Corbevax, which is a two-dose vaccine, soon.The SEC has recommended the EUA only after reviewing the safety and immunogenicity data of the clinical study of Corbevax in children and adolescents.The expected cost of the vaccine is Rs 145 excluding taxes, official sources told ANI.The Corbevax will be the second vaccine after Covaxin which has received EUA for those below 18 years of age. The Hyderabad-based pharmaceutical company will be submitting data soon for clinical trials done on children aged below 12 years, sources said.Union Health Minister Mansukh Mandaviya on Monday informed that over 1.5 crore adolescents in the age group 15-18 years, across the nation are now fully vaccinated against the novel coronavirus infection.According to the sources, the central government has placed an order for Corbevax. The order has been placed for five crore doses.The government of India has placed an order for 30 crore Corbevax doses on August 21 last year.The Hyderabad-based company is expected to deliver the doses this month.The HLL Lifecare Limited, a public sector undertaking has issued the supply order of Corbevax to Biological E.The pharmaceutical company Biological E has also received permission for heterologous booster dose trials.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

CorbevaxFOLLOW

Corbevax, Latest News

Hyderabad, Dec 23 Amidst concerns of a new Covid wave in India following massive surge in China and ... ...

New Delhi, Aug 10 The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for ... ...

New Delhi, Aug 10 The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for ... ...

Hyderabad, April 26 Vaccine maker Biological E. Ltd on Tuesday announced that its Covid-19 vaccine Corbevax has received ... ...

Union Health Minister Mansukh Mandaviya has made a big announcement regarding immunization of children against corona. Mansukh Mandaviya tweeted ... ...

New Delhi, March 14 The Union Government after deliberations with scientific bodies decided on Monday to start Covid ... ...

Hyderabad, Feb 21 Vaccine manufacturer Biological E. Ltd on Monday announced that its Covid-19 vaccine Corbevax has received ... ...

The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to ...